Clinical Trial Update: A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AT2101 (afegostat tartrate) in adults with Type 1 Gaucher disease already on enzyme replacement therapy has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease
• Gaucher Disease Type

Drugs mentioned

• AT2101 (afegostat tartrate) (afegostat tartrate)

Snippet

Sponsor: Amicus Therapeutics | Conditions: Gaucher Disease, Type 1, Type 1 Gaucher Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-08-15